The Vanguard Group 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:15 am Purchase |
2022-12-30 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 5,262,192 11.350% |
295,066 (+5.94%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 4,967,126 10.730% |
383,866 (+8.38%) |
Filing |
| 2021-02-10 10:46 am Sale |
2020-12-31 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 4,583,260 10.300% |
-304,494 (-6.23%) |
Filing |
| 2020-05-08 3:25 pm Purchase |
2020-04-30 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 4,887,754 10.990% |
618,634 (+14.49%) |
Filing |